CIK 0001124105
- Accelerated filer
- Smaller reporting company
GYRE THERAPEUTICS, INC.
Sign in to watch- Ticker
- GYRE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 562020050
- Phone
- +1 858-284-0115
- Business address
- 12730 HIGH BLUFF DRIVE, SUITE 250, SAN DIEGO, CA, 92130
- Former names
- CATALYST BIOSCIENCES, INC., TARGACEPT INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-07-30 | Payne Fletcher Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2018-07-30 | Levy Howard Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +35,000 | 35,000 | ||
| 2018-06-13 | Williams Eddie Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2018-06-13 | Richard John P Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2018-06-13 | LAWLOR AUGUSTINE Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2018-06-13 | Hunt Andrea Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2018-06-13 | HILL STEPHEN A Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2018-06-13 | DESOUZA ERROL B Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2018-05-03 | Levy Howard Chief Medical Officer | Exercise or conversion | +7,560 | $4.63 | $35K | 7,560 |
| 2018-05-03 | Levy Howard Chief Medical Officer | Exercise or conversion · Stock Option (Right to Buy) | −7,560 | 87,440 | ||
| 2018-04-09 | USMAN NASSIM President & CEO | Gift | −88 | 0 | ||
| 2018-04-09 | USMAN NASSIM President & CEO | Gift | +88 | 4,144 | ||
| 2018-04-04 | USMAN NASSIM President & CEO | Exercise or conversion | +88 | $4.63 | $407 | 88 |
| 2018-04-04 | USMAN NASSIM President & CEO | Exercise or conversion · Stock Option (Right to Buy) | −88 | 274,912 | ||
| 2018-03-26 | Payne Fletcher Chief Financial Officer | Exercise or conversion | +59 | $4.63 | $273 | 59 |
| 2018-03-26 | Payne Fletcher Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy) | −59 | 74,941 | ||
| 2018-03-08 | Flynn James E 10% owner | Sale | −866 | $30.00 | $26K | 813,147 |
| 2018-03-08 | Flynn James E 10% owner | Sale | −328 | $30.00 | $10K | 308,198 |
| 2018-03-08 | Flynn James E 10% owner | Sale | −5,890 | $29.03 | $171K | 807,257 |
| 2018-03-08 | Flynn James E 10% owner | Sale | −2,233 | $29.03 | $65K | 305,965 |
Page 20 of 24 · 471 trades